MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Clinical features"

  • 2016 International Congress

    Persistent myoclonic dystonia due to SCL2A1 mutation

    P.H. McNamara, D. Olszewska, A. McCarthy, J. McKinley, T. McVeigh, T. Lynch (Dublin, Ireland)

    Objective: We present a young woman with myoclonic dystonia due to a novel mutation in SCL2A1 gene. Background: Mutations in the SCL2A1 gene can cause…
  • 2016 International Congress

    Children with idiopathic tics reveal additional features of hyperkinetic movement disorders

    P.F. Sinnige, R. Brandsma, W. Eggink, M.J. Kuiper, I.J. Lunsing, M. Boon, C.C.S. Delnooz, M.E. van Egmond, O.G.F. Sinnige, J.J. de Vries, P.J. Hoekstra, D.A. Sival (Groningen, Netherlands)

    Objective: To investigate whether children with tics reveal features of additional hyperkinetic movement disorders. Background: The patho-physiology for idiopathic tic disorders is unknown, although underlying…
  • 2016 International Congress

    Cognitive and behavioral problems in children and adolescents with myoclonus dystonia

    M.A. Coenen, H. Eggink, H. van den Berg, J.M. Spikman, M.A. Tijssen (Groningen, Netherlands)

    Objective: To compare the neuropsychological and behavioral profile of A) children and adolescents with myoclonus dystonia (MD) to a healthy control group and B) MD…
  • 2016 International Congress

    Alternating hemiplegia of childhood (AHC) as a new presentation of adenylate cyclase 5 (ADCY5)-mutation-associated disease

    C. Max, A. Westenberger, N. Brueggemann, A. Domingo, K. Gruetz, H. Pawlack, A. Weissbach, A.A. Kuehn, J. Spiegler, A.E. Lang, J. Sperner, V.S.C. Fung, J. Schallner, G. Gillessen-Kaesbach, A. Muenchau, C. Klein (Lübeck, Germany)

    Objective: To expand and determine the clinical spectrum associated with mutations in the Adenylate Cyclase 5 gene (ADCY5). Background: Recently, mutations in the ADCY5 gene…
  • 2016 International Congress

    Overlapping corticobasal syndromes: The many faces of the Armstrong criteria

    A. Pilotto, W. Maetzler, M. Synofzik, E. Schaeffer, C. Schulte, M.A. Hobert, K. Srulijes, T. Gasser, D. Berg (Tübingen, Germany)

    Objective: To evaluate the prevalence and clinical presentation of corticobasal variants listed in the new Armstrong criteria, exploring their overlap with progressive supranuclear palsy (PSP),…
  • 2016 International Congress

    Three distinct cases of methamphetamine induced movement disorders

    T.A. Clark, J. Kraakevik (Portland, OR, USA)

    Objective: To detail three cases of methamphetamine induced movement disorders with unique clinical phenotypes. Background: MA is an addictive psychostimulant that affects both the central…
  • 2016 International Congress

    Creutzfeldt-Jakob disease presenting predominantly with movement disorder: A case report

    A.A. Sann, M.M. Zaw, T.L. Choie (Yangon, Myanmar)

    Objective: To highlight that Creutzfeldt-Jakob Disease can present predominantly with movement disorder. Background: Creutzfeldt-jakob Disease (CJD) is a rapidly progressive spongioform degeneration of the brain…
  • 2016 International Congress

    Beyond initial clinical phenotype of Madelung disease: Myoclonus, gait disorder and multisystem involvement led to genetic diagnosis

    R. López-Blanco, A. Rojo-Sebastián, M.H. Torregrosa-Martínez, M. Molina-Sánchez, A. Blázquez-Encinar, M.Á. Martín-Casanueva (Madrid, Spain)

    Objective: To report the clinical phenotype of an uncommon hereditary systemic disease with slowly progressive gait and movement disorder with genetic identification of two concurrent…
  • 2016 International Congress

    Familial cortical myoclonic tremor with epilepsy in Chinese population: Clinical and neurophysiologic features in nine pedigrees from People’s Republic of China

    Z. Cen, C. Huang, H. Yin, F. Xie, X. Lu, Z. Ouyang, Y. Lou, X. Qiu, Z. Wang, J. Xiao, M. Ding, W. Luo (Hangzhou, People's Republic of China)

    Objective: To delineate and analyze the clinical and neurophysiologic features of 55 patients from nine Chinese familial cortical myoclonic tremor with epilepsy (FCMTE) pedigrees. Background:…
  • 2016 International Congress

    Post-anoxic myoclonus: Timing matters

    K.G. Su, A.L. Hiller (Portland, OR, USA)

    Objective: To highlight that timing of post-anoxic myoclonus following initial anoxic injury can result in markedly different outcomes. Background: Post-anoxic myoclonus is typically considered a…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley